[Form 3] Biofrontera Inc. Initial Statement of Beneficial Ownership
Rhea-AI Filing Summary
Deutsche Balaton Aktiengesellschaft filed an Initial Statement of Beneficial Ownership reporting direct ownership of 58,884 shares of Biofrontera Inc. (BFRI) and indirect ownership of 400,000 common shares
The filer also reports indirect beneficial ownership of 4,831,172 common shares underlying Series D Convertible Preferred Stock convertible at $0.6249 per share, held by Biofrontera AG. The filer states it and affiliates control ~62.2% of Biofrontera AG voting stock and disclaims direct beneficial ownership except for indirect pecuniary interest. The preferred has no expiration and conversion is limited to prevent over 19.99% ownership on conversion.
Positive
- None.
Negative
- None.
Insights
TL;DR: A large indirect stake is reported via Biofrontera AG, including convertible preferreds that could meaningfully affect common share count on conversion.
The filing shows Deutsche Balaton Aktiengesellschaft directly holds 58,884 common shares and indirectly holds 400,000 common shares plus economic exposure to 4,831,172 common shares via Series D Convertible Preferred Stock convertible at $0.6249 per share. The report explicitly states the filer and affiliates control ~62.2% of Biofrontera AG's voting stock, explaining the basis for indirect beneficial ownership. The convertible preferred has no expiration and contains a conversion limitation capping beneficial ownership post-conversion at 19.99%, which may constrain immediate dilution but signals potential future common share issuance if conditions permit.
TL;DR: This Form 3 documents initial reporting by a significant insider/affiliate with both direct and broad indirect economic interests.
The filing identifies the reporting person as a Director and indicates ownership both directly and indirectly through Biofrontera AG. The disclosure and the disclaimer language are standard: indirect pecuniary interest is claimed and direct beneficial ownership is disclaimed except as to that interest. The conversion feature of the preferred stock and the 19.99% ownership cap are explicit contractual terms that affect voting and control dynamics if conversion occurs. For governance, the combination of direct stake, large indirect exposure, and affiliate control of Biofrontera AG is material to shareholder control dynamics.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Series D Convertible Preferred Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The reported shares are held directly by Biofrontera AG. The Reporting Person and its affiliates collectively hold approximately 62.2% of the outstanding voting stock of Biofrontera AG and therefore may be deemed to beneficially own the shares owned by Biofrontera AG. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. The convertible preferred stock is convertible at any time at the holder's option, subject to a limitation that prevents the holder and its affiliates from beneficially owning more than 19.99% of the outstanding common stock upon conversion. The preferred stock has no expiration date.
